Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




German-Israeli Center for Brain Research Dedicated in Recent Ceremony

By LabMedica International staff writers
Posted on 21 Jan 2013
A new center for collaborative brain research between German and Israeli scientists was dedicated in a ceremony held recently in Jerusalem.

The new center, called the Max Planck-Hebrew University Center for Sensory Processing of the Brain in Action, will be staffed by researchers from the Max Planck Institute of Neurobiology (Martinsried, Germany) and the Edmond and Lily Safra Center for Brain Sciences at the Hebrew University of Jerusalem (Israel).

The new center, which is to be housed at the Hebrew University of Jerusalem, will be funded at three million euros for its first five years. More...
It is one of only nine such international partnerships between the Max Planck Society and a foreign research institution and is the only one in the field of brain research.

Researchers from the two institutions will be studying both individual nerve cells as well as circuits of cells and analyzing how sensory perceptions are processed in the brain. These topics mesh well with the Hebrew University's interdisciplinary approach that includes neuroscientists, physicists, computer scientists, cognitive scientists, and others who focus on several broad areas of inquiry, including genes and neurons, neural networks learning and plasticity, cognitive neuroscience, computational neuroscience, and sensory and motor functions.

Special emphasis will be placed on recruiting young Israeli and German investigators through fellowships and joint research programs.

“The center raises our long-standing partnership in the field of neuroscience to a new level of quality. It offers the prospect of an entirely new dimension in the study of the brain in particular,” said Dr. Peter Gruss, the president of the Max Planck Society.

President of the Hebrew University of Jerusalem Dr. Menahem Ben-Sasson, said, “Cooperation with Germany in science and research is among the most important and fruitful of our international contacts, and makes it possible for us to be at the forefront of science. We are happy to be one of the first universities in the world outside of Germany in which a joint research center is being established with the Max Planck Society, and look forward to further cooperation in the future.”

Related Links:

Max Planck Institute of Neurobiology
Hebrew University of Jerusalem



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.